-
公开(公告)号:US20240038387A1
公开(公告)日:2024-02-01
申请号:US18483632
申请日:2023-10-10
发明人: Lonny Stormo , Daniel William Davis , Curtis Jerome Christensen , Jennifer E. Englund , Timothy Balder
IPC分类号: G16H40/67 , G06Q10/1093 , G16H20/10 , G16H10/60 , G16H80/00
摘要: Devices, systems, and processes are disclosed herein relating to the collection, transmission, and/or use of physiological condition information (e.g., blood glucose information) for a remote healthcare determination. One embodiment includes a physiological condition information system. This system embodiment includes a physiological condition management device and a remote server. The physiological condition management device can be at a first location (e.g., accompanying a patient at the first location) and the remote server can be at a second location that is different from the first location. The physiological condition management device and remote server can be in data communication over a transmission link. The physiological condition management device is configured to collect physiological condition information associated with the patient and send this information over the transmission link to the remote server. Upon receiving the physiological condition information, the remote server is configured to send a data communication to a remote healthcare provider.
-
公开(公告)号:US20230207121A1
公开(公告)日:2023-06-29
申请号:US18179529
申请日:2023-03-07
发明人: LONNY STORMO , DANIEL WILLIAM DAVIS , CURTIS JEROME CHRISTENSEN , JENNIFER E. ENGLUND , TIMOTHY BALDER
IPC分类号: G16H40/67 , G06Q10/1093 , G16H20/10 , G16H10/60 , G16H80/00
摘要: Devices, systems, and processes are disclosed herein relating to the collection, transmission, and/or use of physiological condition information (e.g., blood glucose information) for a remote healthcare determination. One embodiment includes a physiological condition information system. This system embodiment includes a physiological condition management device and a remote server. The physiological condition management device can be at a first location (e.g., accompanying a patient at the first location) and the remote server can be at a second location that is different from the first location. The physiological condition management device and remote server can be in data communication over a transmission link. The physiological condition management device is configured to collect physiological condition information associated with the patient and send this information over the transmission link to the remote server. Upon receiving the physiological condition information, the remote server is configured to send a data communication to a remote healthcare provider.
-
公开(公告)号:US10219732B2
公开(公告)日:2019-03-05
申请号:US15122284
申请日:2016-08-27
摘要: A biological property testing device includes a base comprising a primary surface extending in a base plane, and a first lancet station supported by the base. A first test strip channel provided in the base can have a main channel portion extending generally parallel with the base plane, and an angled channel portion that forms an angle with the main channel portion between 5 degrees and 90 degrees. The first test strip channel can house a biological test strip oriented so that a meter connecting end of the biological test strip is adjacent to the main channel portion and a sample end of the biological test strip is adjacent to the angled channel portion.
-
公开(公告)号:US20160324464A1
公开(公告)日:2016-11-10
申请号:US15149119
申请日:2016-05-07
发明人: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stormo
CPC分类号: A61B5/7275 , A61B5/0022 , A61B5/1118 , A61B5/1176 , A61B5/14532 , A61B5/151 , A61B5/157 , A61B5/486 , A61B5/6898 , A61B5/7282 , A61B5/742 , A61B5/746 , A61B5/7475 , A61B2562/0295 , G06F19/321 , G06F19/3475 , G06F19/3481 , G06Q30/0269 , G06Q30/0277 , G09B5/125 , G09B19/0092 , G16H10/20 , G16H40/63 , H04L63/10
摘要: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
-
公开(公告)号:US20230386640A1
公开(公告)日:2023-11-30
申请号:US18449332
申请日:2023-08-14
发明人: Curtis Christensen , Daniel Davis , Erik Davis , Chandler Stormo , Lonny Stormo
IPC分类号: G16H20/30 , A61B5/00 , A61B5/145 , A61B5/151 , A61B5/157 , A61B5/11 , A61B5/1171 , G16H40/63 , G16H10/20 , G16H40/60 , G16H10/60 , G06Q30/0251 , G06Q30/0241 , G09B5/12 , G09B19/00 , H04L9/40
CPC分类号: G16H20/30 , A61B5/486 , A61B5/6898 , A61B5/14532 , A61B5/151 , A61B5/157 , A61B5/1118 , A61B5/1176 , A61B5/7275 , A61B5/0022 , A61B5/742 , A61B5/7475 , G16H40/63 , G16H10/20 , G16H40/60 , G16H10/60 , A61B5/7282 , A61B5/746 , G06Q30/0269 , G06Q30/0277 , G09B5/125 , G09B19/0092 , H04L63/10 , A61B2562/0295
摘要: Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.
-
公开(公告)号:US20190150816A1
公开(公告)日:2019-05-23
申请号:US16250636
申请日:2019-01-17
摘要: A biological property testing device includes a base comprising a primary surface extending in a base plane, and a first lancet station supported by the base. A first test strip channel provided in the base can have a main channel portion extending generally parallel with the base plane, and an angled channel portion that forms an angle with the main channel portion between 5 degrees and 90 degrees. The first test strip channel can house a biological test strip oriented so that a meter connecting end of the biological test strip is adjacent to the main channel portion and a sample end of the biological test strip is adjacent to the angled channel portion.
-
公开(公告)号:US20240000353A1
公开(公告)日:2024-01-04
申请号:US18470167
申请日:2023-09-19
CPC分类号: A61B5/150572 , A61B5/15101 , A61B5/150267 , A61B5/150862 , A61B5/15087 , A61B5/15151 , A61B5/15163 , A61B5/150022 , A61B5/150412 , A61B5/150969 , A61B5/15105 , A61B5/15142 , A61B5/150358 , A61B5/157 , A61B5/150893 , A61B5/1411 , A61B5/14532 , A61B5/7405 , A61B5/742 , A61B5/7455 , A61B5/15019 , A61B5/150213 , A61B5/150503 , A61B5/150633 , A61B5/150664 , A61B5/15144 , A61B2560/0443 , A61B5/7445 , A61B2562/0295
摘要: This disclosure provides equipment and processes for blood glucose management. Embodiments may comprise a lancet device that includes a base that supports a lancet and a cover. The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. In another aspect, a biological test kit may include a reusable module and a disposable module. The disposable module may include one or more lancet devices such as that described above to collect a biological sample, one or more strip stations supporting biological strips and a disposable module connector. The reusable module may support measuring equipment to measure a property of the biological sample and a reusable module connector that engages removably with the disposable module connector.
-
公开(公告)号:US20220409108A1
公开(公告)日:2022-12-29
申请号:US17898036
申请日:2022-08-29
IPC分类号: A61B5/151 , A61B5/15 , A61B5/157 , A61B5/1468 , A61B5/00 , A61B17/3209 , A61B17/34
摘要: The biological test kit is a device for drawing and, optionally, testing biological samples. The biological test kit is an array of lancets set in wells in a rigid base. Each lancet well is covered by a protective cover which when deformed permits the lancet to puncture a user or other patient. In one embodiment the biological test kit employs distinct covers for each lancet and in another the covers are formed from sheet material formed into blisters which cover the lancet.
-
公开(公告)号:US20200170556A1
公开(公告)日:2020-06-04
申请号:US16779940
申请日:2020-02-03
IPC分类号: A61B5/151 , A61B17/34 , A61B17/3209 , A61B5/00 , A61B5/1468 , A61B5/15 , A61B5/157
摘要: The biological test kit is a device for drawing and, optionally, testing biological samples. The biological test kit is an array of lancets set in wells in a rigid base. Each lancet well is covered by a protective cover which when deformed permits the lancet to puncture a user or other patient. In one embodiment the biological test kit employs distinct covers for each lancet and in another the covers are formed from sheet material formed into blisters which cover the lancet.
-
公开(公告)号:US20170231542A1
公开(公告)日:2017-08-17
申请号:US15586460
申请日:2017-05-04
IPC分类号: A61B5/151 , A61B17/3209 , A61B5/00 , A61B5/15 , A61B5/157 , A61B17/34 , A61B5/1468
CPC分类号: A61B5/15151 , A61B5/1411 , A61B5/1468 , A61B5/150022 , A61B5/150282 , A61B5/150305 , A61B5/150358 , A61B5/150412 , A61B5/150572 , A61B5/150969 , A61B5/150977 , A61B5/15105 , A61B5/15142 , A61B5/15157 , A61B5/15176 , A61B5/15186 , A61B5/157 , A61B5/742 , A61B17/32093 , A61B17/3421 , A61B2017/32113
摘要: The biological test kit is a device for drawing and, optionally, testing biological samples. The biological test kit is an array of lancets set in wells in a rigid base. Each lancet well is covered by a protective cover which when deformed permits the lancet to puncture a user or other patient. In one embodiment the biological test kit employs distinct covers for each lancet and in another the covers are formed from sheet material formed into blisters which cover the lancet.
-
-
-
-
-
-
-
-
-